Risk of Thromboembolic Events in Patients with Non-Valvular Atrial Fibrillation After Dabigatran or Rivaroxaban Discontinuation - Data from the Ljubljana Registry.

BACKGROUND AND AIM:Interruption of anticoagulant treatment with warfarin or non-vitamin K antagonist oral anticoagulants (NOAC) represents a vulnerable period with an increased risk of thromboembolic events. What is the incidence of thromboembolic events in real-life patients with non-valvular atria...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Nina Vene, Alenka Mavri, Mirjam Gubenšek, Gregor Tratar, Tjaša Vižintin Cuderman, Maja Pohar Perme, Aleš Blinc
格式: Artigo
語言:Inglês
出版: Public Library of Science (PLoS) 2016-01-01
叢編:PLoS ONE
在線閱讀:http://europepmc.org/articles/PMC4900606?pdf=render
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍